CFRX ContraFect Corporation

2.08
+0.03  (+1%)
Previous Close 2.05
Open 2.06
Price To Book -208
Market Cap 165171876
Shares 79,409,556
Volume 294,825
Short Ratio
Av. Daily Volume 243,079

Drug Information

Drug catalyst information is displayed when you hover over the stage bar graph.

Phase 2 data due 4Q 2018.
CF-301
Serious infections caused byStaph aureus including MRSA

SEC Filings

  1. EFFECT - Notice of Effectiveness 181234465
  2. SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals 181221019
  3. S-3 - Registration statement under Securities Act of 1933 181211888
  4. 8-K - Current report 181170298
  5. 10-Q - Quarterly report [Sections 13 or 15(d)] 181169836
  6. 10-Q - Quarterly report [Sections 13 or 15(d)] 181005986
  7. 8-K - Current report 181005035
  8. 8-K - Current report 18981158
  9. 424B5 - Prospectus [Rule 424(b)(5)] 18975374
  10. 424B5 - Prospectus [Rule 424(b)(5)] 18972626